Structure Therapeutics to participate in upcoming healthcare investor conferences
Structure Therapeutics Inc. said management will participate in three healthcare investor conferences, as outlined in its latest announcement.
SAN FRANCISCO, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc.
NASDAQ:GPCR, a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in three u…